2m 2m 2m 2m 2m 2m 2m
Virax Biolabs (VRAX)
NASDAQ
$4.09+$0.02 (+0.49%)
Price as of Jul 14, 2026 6:45 AM EDT- $417.1MMarket Cap
- -82.42%1-Year Change
- BiotechnologyIndustry
Virax Biolabs (VRAX)
$4.09+$0.02 (+0.49%)
VRAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.07 | ||
Change | -$0.010 (-0.25%) | ||
Open | $3.79 | ||
High | $4.62 | ||
Low | $3.66 | ||
Previous Close | $4.08 | ||
Volume | 986,638 | ||
30-Day Average Volume | 4,123,095 | ||
1-Week Change | 30.87% | ||
1-Month Change | -11.52% | ||
1-Year Change | -82.42% | ||
3-Year Change | -95.83% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 102.5M | ||
Total Assets | $8.3M | ||
Market Cap | $417.1M | ||
Enterprise Value | $410.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 06/26/2026 | ||
Earnings & Revenue